The Enterprise Value as of November 2024 (TTM) for Inventiva S.A. (IVA) is 231.01M

According to Inventiva S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 231.01M. This represents a change of 87.85% compared to the average of 122.97M of the last 4 quarters.

Inventiva S.A. (IVA) Historical Enterprise Value (quarterly & annually)

How has IVA Enterprise Value performed in the past?

The mean historical Enterprise Value of Inventiva S.A. over the last ten years is 194.02M. The current 231.01M Enterprise Value has changed 11.81% with respect to the historical average. Over the past ten years (40 quarters), IVA's Enterprise Value was at its highest in in the December 2021 quarter at 464.60M. The Enterprise Value was at its lowest in in the January 2013 quarter at 0.

Inventiva S.A. (IVA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Inventiva S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Inventiva S.A. (IVA) Average Enterprise Value

How has IVA Enterprise Value performed in the past?

The current Enterprise Value of Inventiva S.A. (IVA) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Inventiva S.A. (IVA) Enterprise Value vs. Peers

How is IVA’s Enterprise Value compared to its peers?

Inventiva S.A.’s Enterprise Value is less than Mineralys Therapeutics, Inc. (603.45M), greater than Eliem Therapeutics, Inc. (119.64M), greater than Anebulo Pharmaceuticals, Inc. (45.92M), less than Janux Therapeutics, Inc. (2.92B), less than Rezolute, Inc. (236.08M), less than Monte Rosa Therapeutics, Inc. (478.04M), less than NewAmsterdam Pharma Company N.V. (1.09B), less than Cullinan Oncology, Inc. (810.70M), greater than Compass Therapeutics, Inc. (211.64M), less than Arcellx, Inc. (4.62B), greater than Ventyx Biosciences, Inc. (122.28M), less than Immunocore Holdings plc (1.53B), less than Vaxcyte, Inc. (12.48B), less than DICE Therapeutics, Inc. (2.21B), greater than Verrica Pharmaceuticals Inc. (75.40M), greater than LianBio (-66141903.00), less than Edgewise Therapeutics, Inc. (3.19B), greater than Vigil Neuroscience, Inc. (129.53M), greater than Innate Pharma S.A. (101.12M), greater than HCW Biologics Inc. (25.13M), greater than Inhibrx Biosciences, Inc. (411.31K),

Build a custom stock screener for Inventiva S.A. (IVA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Inventiva S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Inventiva S.A. (IVA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Inventiva S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.